How did you decide to participate in the Biomapas Academy?
The first thing that caught my attention was the Biomapas Academy poster hanging on my university’s bulletin board. Shortly afterwards, the faculty management shared Biomapas’ invitation to register for the first Biomapas Academy. I wanted to learn more about this company, so I decided to take my chances and apply to the Academy. I was thrilled when I received a call with the happy news that I had successfully passed the selection process and was invited to attend the Academy.
What was your experience during the three months?
I listened to many interesting lectures, during which we got to know the company and its areas of activity. We listened to lectures on clinical trials and their organization, pharmacovigilance, regulatory affairs, bioethics, drug registration, and more. I believe that the knowledge gained at the Academy is valuable and helpful for all participants of the Academy and their future careers.
What did the future hold for you after the Academy?
I mainly was interested in pharmacovigilance, so we agreed on an internship in this department during the summer. Interesting fact: the first Biomapas poster I saw was about pharmacovigilance! And the best thing is that after the internship, I was able to join and become a part of this great team. I am happy to be here and to learn from real professionals in this field.
What would you say to the future participants?
I want to encourage everyone who is thinking about participating in the Biomapas Academy. Being at the Academy is exciting and worthwhile. By joining the Academy, you will broaden your horizons, learn from global professionals, improve your life sciences knowledge, and gain valuable experience. I wish good luck to all participants. See you soon at Biomapas!
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
The Perfect Partnership: How Mid-Sized CROs and Site Networks Deliver Clinical Trial Success
In this webinar, learn how the right size of CRO and the right type of site network partnership can deliver clinical trial success.
Breaking the Silos Across Medical Information & Pharmacovigilance – Leveraging Technology for Operational Efficiency
This whitepaper shows how a PV/MI Single Source of Truth boosts data management, compliance, and efficiency for complex therapies.
Harmonizing Product Information Across Baltic Markets
Navigating multilingual product information across several markets can be complex – but it doesn’t have to be. In this case study, we share how one of our partner companies successfully harmonized their SmPC, PIL, and labelling across the Baltic region, working with...
Dossier Transformation for Market Expansion
Struggling with outdated dossiers and complex regulatory requirements? We partnered with a large pharma company to transform a fragmented legacy submission into a fully CTD-compliant dossier for successful market expansion in Europe. In this case study, we break down...
Whitepaper: Computerised System Validation & Pharmacovigilance
This whitepaper explores how optimised computer system validation (CSV) strategies strengthen risk management, ensure data integrity in pharmacovigilance systems, and support compliance through a real-world cloud-based safety database case study.
Unlock Trial Success with the FSP Hybrid Model
Learn how the FSP hybrid model combines the best of FSO and FSP in clinical trials, enhancing operational control and flexibility.
Breaking silos across Medical Information & Pharmacovigilance
Discover solutions for effective PV & MI data management, including handling Adverse Events, Product Quality Complaints, and MI inquiries. Our experts will walk you through real-life examples and hands-on solutions.
Unlocking Success. The FSP Advantage in Clinical Research
FSP is a rising trend in clinical research, expected to gain further prominence due to its cost-effectiveness and demand for specialised expertise. Our FSP model offers benefits such as cost savings, expert advice, flexibility, and risk mitigation. Let’s discuss how...
Affiliate Based Outsourcing Model for Regulatory Affairs.
Affiliate based Outsourcing Model for Regulatory Affairs works as a replacement or an extension of the company’s internal and local RA resources. Many challenges come up from managing your RA activities as sometimes their processes are not harmonized across different...
Regulatory Outsourcing in the CEE Region
In this informative session we decode the intricate landscape of regulatory affairs outsourcing in the CEE region and provide practical, implementable strategies to optimize and maximize your operations and outsourcing strategies.Let’s discuss how we can streamline...
